Form 10-Q - Quarterly report [Sections 13 or 15(d)]

US Dollar vs MXN

Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

Regístrate

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

PAVmed (NASDAQ:PAVM)
Gráfica de Acción Histórica
De Mar 2025 a Abr 2025

Haga Click aquí para más Gráficas PAVmed.

PAVmed (NASDAQ:PAVM)
Gráfica de Acción Histórica
De Abr 2024 a Abr 2025

Haga Click aquí para más Gráficas PAVmed.

Noticias sobre PAVmed Inc PAVM

Lucid Diagnostics to Participate in Fireside Chat at the 24th Annual Needham Virtual Healthcare Conference
Jueves 3 de Abril 2025 (3 días hace) • PR Newswire (US)

Lucid Diagnostics Launches "Embrace the Future" Campaign Showcasing EsoCheck's Groundbreaking Collect+Protect Esophageal Cell Collection Technology
Jueves 27 de Marzo 2025 (1 semana hace) • PR Newswire (US)

PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results
Martes 25 de Marzo 2025 (2 semanas hace) • PR Newswire (US)

Lucid Diagnostics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results
Lunes 24 de Marzo 2025 (2 semanas hace) • PR Newswire (US)

Lucid Diagnostics Announces Updated National Comprehensive Cancer Network® (NCCN) Guidelines Now Include Esophageal Precancer Screening
Jueves 20 de Marzo 2025 (2 semanas hace) • PR Newswire (US)

Lucid Diagnostics' ENVET-BE Clinical Utility Study of EsoGuard® Esophageal Precancer Testing Accepted for Peer-Reviewed Publication
Martes 18 de Marzo 2025 (3 semanas hace) • PR Newswire (US)

Lucid Diagnostics Secures First Positive Commercial Insurance Coverage Policy for its EsoGuard® Esophageal DNA Test
Jueves 13 de Marzo 2025 (3 semanas hace) • PR Newswire (US)

PAVmed to Hold a Business Update Conference Call and Webcast on March 25, 2025
Martes 11 de Marzo 2025 (4 semanas hace) • PR Newswire (US)

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on March 24, 2025
Lunes 10 de Marzo 2025 (4 semanas hace) • PR Newswire (US)

Lucid Diagnostics Announces Closing of $15.3 Million Registered Direct Offering
Miércoles 5 de Marzo 2025 (1 mes hace) • PR Newswire (US)

Lucid Diagnostics Announces $15.3 Million Registered Direct Offering
Martes 4 de Marzo 2025 (1 mes hace) • PR Newswire (US)

Renowned Investigators Awarded $8 Million NIH Grant to Study Lucid Diagnostics' EsoGuard® in At-Risk Patients without Symptomatic GERD
Jueves 27 de Febrero 2025 (1 mes hace) • PR Newswire (US)

Más de PAVmed Inc Artículos de Noticias

Invesco QQQ Trust Series 1

Financial Select Sector

Health Care Select Sector

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones